Targeting phosphodiesterase 3B enhances cisplatin sensitivity in human cancer cells

We previously reported that human squamous cell carcinoma (SCC) cell lines refractory to cis-diaminedichloro-platinum II (cisplatin [CDDP]) had significant upregulation of the phosphodiesterase 3B gene (PDE3B), suggesting that inhibiting PDE3B suppresses CDDP resistance. shRNA-mediated PDE3B depleti...

Descripción completa

Detalles Bibliográficos
Autores principales: Uzawa, Katsuhiro, Kasamatsu, Atsushi, Baba, Takao, Usukura, Katsuya, Saito, Yasuhiro, Sakuma, Kentaro, Iyoda, Manabu, Sakamoto, Yosuke, Ogawara, Katsunori, Shiiba, Masashi, Tanzawa, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797561/
https://www.ncbi.nlm.nih.gov/pubmed/24133626
http://dx.doi.org/10.1002/cam4.56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797561/
https://www.ncbi.nlm.nih.gov/pubmed/24133626
http://dx.doi.org/10.1002/cam4.56

Ejemplares similares